[CRBP] Corbus Pharmaceuticals Holdings, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 127.66 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 8.55 Change: 0.2 (2.4%)
Ext. hours: Change: 0 (0%)

chart CRBP

Refresh chart

Fundamental Ratios
Shares Outstanding43.57 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV27.21 Price/Cash Per Share
Price/Free Cash Flow ROA-71.41% ROE-79.86% ROI
Current Ratio9.34 Quick Ratio Long Term Debt/Equity Debt Ratio0.12
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-10 K Cash From Investing Activities Cash From Operating Activities-1.28 M Gross Profit
Net Profit-1.54 M Operating Profit-1.54 M Total Assets5.25 M Total Current Assets5.18 M
Total Current Liabilities550 K Total Debt70 K Total Liabilities550 K Total Revenue
Technical Data
High 52 week8.95 Low 52 week4.65 Last close5.88 Last change2.26%
RSI41.5 Average true range0.32 Beta1.24 Volume250.54 K
Simple moving average 20 days-2% Simple moving average 50 days-10.22% Simple moving average 200 days-15.01%
Performance Data
Performance Week4.07% Performance Month-11.84% Performance Quart-21.7% Performance Half-23.44%
Performance Year26.45% Performance Year-to-date0.68% Volatility daily1.96% Volatility weekly4.39%
Volatility monthly8.99% Volatility yearly31.14% Relative Volume223.98% Average Volume719.37 K
New High New Low

News

2020-06-01 09:00:01 | Is Corbus Pharmaceuticals CRBP Stock a Solid Choice Right Now?

2020-06-01 08:05:10 | Corbus Pharmaceuticals Announces Publication of Phase 2b Cystic Fibrosis Study Patient Demographics and Baseline Disease Characteristics in the Journal of Cystic Fibrosis

2020-05-28 06:53:17 | Will Corbus Pharmaceuticals Holdings NASDAQ:CRBP Spend Its Cash Wisely?

2020-05-27 08:05:10 | Corbus Pharmaceuticals Reports Last Subject Visit in RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis

2020-05-22 08:05:10 | Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2020 E-Congress

2020-05-17 21:35:24 | Edited Transcript of CRBP earnings conference call or presentation 11-May-20 12:30pm GMT

2020-05-15 12:00:04 | Corbus Pharmaceuticals CRBP Moves to Buy: Rationale Behind the Upgrade

2020-05-15 08:05:10 | Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences

2020-05-14 09:30:01 | Do Options Traders Know Something About Corbus Pharmaceuticals CRBP Stock We Don't?

2020-05-11 09:55:01 | Corbus Pharmaceuticals CRBP Reports Q1 Loss, Tops Revenue Estimates

2020-05-11 07:05:10 | Corbus Pharmaceuticals Reports First Quarter Financial Results and Corporate Updates

2020-05-04 08:05:10 | Corbus Pharmaceuticals to Report First Quarter Results on May 11, 2020

2020-04-30 16:15:10 | Viela Bio Announces Election of Rachelle Jacques to its Board of Directors

2020-04-29 08:05:10 | Corbus Announces Publication of Lenabasum Systemic Sclerosis Double-Blind, Placebo-Control Phase 2 Clinical Trial Results in Arthritis & Rheumatology

2020-04-28 07:05:58 | Corbus Pharmaceuticals Holdings NASDAQ:CRBP Shareholders Booked A 86% Gain In The Last Five Years

2020-04-02 08:58:12 | Implied Volatility Surging for Corbus CRBP Stock Options

2020-03-31 21:20:22 | Edited Transcript of CRBP earnings conference call or presentation 12-Mar-20 12:30pm GMT

2020-03-14 08:52:54 | Corbus Pharmaceuticals Holdings, Inc. Just Reported Earnings, And Analysts Cut Their Target Price

2020-03-12 08:55:12 | Corbus Pharmaceuticals CRBP Reports Q4 Loss, Lags Revenue Estimates

2020-03-12 07:05:10 | Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results

2020-03-12 06:30:00 | Corbus Pharmaceuticals Holdings, Inc. to Host Earnings Call

2020-03-10 08:05:10 | Corbus Pharmaceuticals Announces Changes to its Board and Appointment of Pete Salzmann, M.D. as Independent Director

2020-03-10 07:14:17 | Did Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP Insiders Buy Up More Shares?

2020-03-05 08:05:10 | Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020

2020-03-03 12:30:05 | Earnings Preview: Corbus Pharmaceuticals CRBP Q4 Earnings Expected to Decline

2020-02-11 16:01:10 | Corbus Pharmaceuticals Announces Closing of $46 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares

2020-02-10 08:58:01 | Are Options Traders Betting on a Big Move in Corbus Pharmaceuticals CRBP Stock?

2020-02-07 09:02:41 | Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock

2020-02-06 16:01:10 | Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock

2020-01-25 08:09:49 | Is Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP A Volatile Stock?

2019-12-19 08:07:59 | Does Corbus Pharmaceuticals Holdings, Inc.'s NASDAQ:CRBP CEO Pay Matter?

2019-12-17 16:07:07 | Hedge Funds Are Selling Corbus Pharmaceuticals Holdings Inc CRBP

2019-12-09 08:05:10 | Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System

2019-11-18 08:17:26 | Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis

2019-11-14 15:13:48 | Edited Transcript of CRBP earnings conference call or presentation 7-Nov-19 1:30pm GMT

2019-11-12 08:05:00 | Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London

2019-11-12 07:20:14 | We Think Corbus Pharmaceuticals Holdings NASDAQ:CRBP Can Afford To Drive Business Growth

2019-11-11 08:05:00 | Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting

2019-11-07 11:15:04 | Corbus Pharmaceuticals CRBP Reports Q3 Loss, Tops Revenue Estimates

2019-11-07 07:05:00 | Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates

2019-11-05 13:00:16 | 3 Under-the-Radar Stocks Top Insiders Are Snapping Up

2019-11-04 08:05:00 | Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Operational and Financial Results on November 7, 2019

2019-11-01 12:08:28 | Were Hedge Funds Right About Selling Corbus Pharmaceuticals CRBP?

2019-10-13 10:06:29 | What Percentage Of Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP Shares Do Insiders Own?

2019-10-03 08:05:00 | Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting

2019-10-01 09:03:00 | Marijuana stocks are oversold — here’s how to know when to buy them

2019-09-13 07:21:17 | Health Check: How Prudently Does Corbus Pharmaceuticals Holdings NASDAQ:CRBP Use Debt?

2019-08-14 08:32:28 | Have Insiders Been Buying Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP Shares This Year?

2019-08-14 01:35:00 | Corbus Pharmaceuticals Holdings, Inc. CRBP Q2 2019 Earnings Call Transcript

2019-08-12 12:48:31 | Edited Transcript of CRBP earnings conference call or presentation 8-Aug-19 12:30pm GMT